Could a common Alzheimer's drug tame heart palpitations?
NCT ID NCT06501638
First seen Nov 19, 2025 · Last updated May 23, 2026 · Updated 24 times
Summary
This study tested whether memantine, a drug typically used for Alzheimer's, can safely reduce the number of extra heartbeats (atrial premature beats) in people who have frequent, bothersome symptoms. A total of 256 adults with at least 1,000 extra beats per day participated. The trial was double-blind and placebo-controlled, meaning neither patients nor doctors knew who got the real drug, to ensure fair results.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL PREMATURE BEATS, CONTRACTIONS, OR SYSTOLES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Shanghai East Hospital
Shanghai, Shanghai Municipality, 200120, China
Conditions
Explore the condition pages connected to this study.